THU0381 MANAGEMENT OF CARDIOVASCULAR COMORBIDITY IN PSORIATIC ARTHRITIS IN THE ROUTINE CLINICAL PRACTICE: A COMPARATIVE STUDY OF METHOTREXATE OR APREMILAST AS MONOTHERAPY AND COMBINED

MLA

M. J. Pérez Galán, et al. “Thu0381 Management of Cardiovascular Comorbidity in Psoriatic Arthritis in the Routine Clinical Practice: A Comparative Study of Methotrexate or Apremilast as Monotherapy and Combined.” Annals of the Rheumatic Diseases, vol. 79, June 2020, pp. 424–25. EBSCOhost, https://doi.org/10.1136/annrheumdis-2020-eular.5447.

APA

M. J. Pérez Galán, C. Lopez-Pedrera, G. G. Ignacio, A. M. Patiño-Trives, D. Ruiz, E. Collantes Estevez, A. Escudero Contreras, Carmen Torres-Granados, N. Barbarroja Puerto, M. D. López Montilla, I. Añón Oñate, I. Arias de la Rosa, M. D. C. Abalos-Aguilera, & María Luque-Tévar. (2020). Thu0381 Management of Cardiovascular Comorbidity in Psoriatic Arthritis in the Routine Clinical Practice: A Comparative Study of Methotrexate or Apremilast as Monotherapy and Combined. Annals of the Rheumatic Diseases, 79, 424–425. https://doi.org/10.1136/annrheumdis-2020-eular.5447

Chicago

M. J. Pérez Galán, C. Lopez-Pedrera, G. G. Ignacio, A. M. Patiño-Trives, D. Ruiz, E. Collantes Estevez, A. Escudero Contreras, et al. 2020. “Thu0381 Management of Cardiovascular Comorbidity in Psoriatic Arthritis in the Routine Clinical Practice: A Comparative Study of Methotrexate or Apremilast as Monotherapy and Combined.” Annals of the Rheumatic Diseases 79 (June): 424–25. doi:10.1136/annrheumdis-2020-eular.5447.